XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Statements of Convertible Preferred Stock and Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Series A Convertible Preferred Stock
Series A-1 Convertible Preferred Stock
Series B Convertible Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2019 $ (17,102)       $ 1 $ 3,204 $ (20,307)  
Beginning balance, shares at Dec. 31, 2019   40,000,000 16,000,000          
Beginning balance at Dec. 31, 2019   $ 37,383 $ 19,307          
Beginning balance, shares at Dec. 31, 2019         6,390,137      
Stock-based compensation expense 123         123    
Net loss (4,848)           (4,848)  
Unrealized loss on marketable securities 13             $ 13
Ending balance at Mar. 31, 2020 (21,814)       $ 1 3,327 (25,155) 13
Ending balance, shares at Mar. 31, 2020   40,000,000 16,000,000          
Ending balance at Mar. 31, 2020   $ 37,383 $ 19,307          
Ending balance, shares at Mar. 31, 2020         6,390,137      
Beginning balance at Dec. 31, 2019 (17,102)       $ 1 3,204 (20,307)  
Beginning balance, shares at Dec. 31, 2019   40,000,000 16,000,000          
Beginning balance at Dec. 31, 2019   $ 37,383 $ 19,307          
Beginning balance, shares at Dec. 31, 2019         6,390,137      
Net loss (15,928)              
Unrealized loss on marketable securities 8              
Ending balance at Sep. 30, 2020 (32,042)       $ 1 4,184 (36,235) 8
Ending balance, shares at Sep. 30, 2020   40,000,000 28,000,000 62,499,993        
Ending balance at Sep. 30, 2020   $ 37,383 $ 34,276 $ 114,496        
Ending balance, shares at Sep. 30, 2020         6,985,928      
Beginning balance at Dec. 31, 2019 (17,102)       $ 1 3,204 (20,307)  
Beginning balance, shares at Dec. 31, 2019   40,000,000 16,000,000          
Beginning balance at Dec. 31, 2019   $ 37,383 $ 19,307          
Beginning balance, shares at Dec. 31, 2019         6,390,137      
Net loss (22,700)              
Ending balance at Dec. 31, 2020 (38,147)       $ 1 4,879 (43,014) (13)
Ending balance, shares at Dec. 31, 2020   40,000,000 28,000,000 62,499,993        
Ending balance at Dec. 31, 2020 $ 186,151 $ 37,383 $ 34,272 $ 114,496        
Ending balance, shares at Dec. 31, 2020 7,087,130       7,087,130      
Beginning balance at Mar. 31, 2020 $ (21,814)       $ 1 3,327 (25,155) 13
Beginning balance, shares at Mar. 31, 2020   40,000,000 16,000,000          
Beginning balance at Mar. 31, 2020   $ 37,383 $ 19,307          
Beginning balance, shares at Mar. 31, 2020         6,390,137      
Issuance of common stock upon exercise of stock options 25         25    
Issuance of common stock upon exercise of stock options, shares         26,530      
Stock-based compensation expense 119         119    
Net loss (4,663)           (4,663)  
Unrealized loss on marketable securities 7             7
Ending balance at Jun. 30, 2020 (26,326)       $ 1 3,471 (29,818) 20
Ending balance, shares at Jun. 30, 2020   40,000,000 16,000,000          
Ending balance at Jun. 30, 2020   $ 37,383 $ 19,307          
Ending balance, shares at Jun. 30, 2020         6,416,667      
Issuance of common stock upon exercise of stock options 526         526    
Issuance of common stock upon exercise of stock options, shares         569,261      
Issuance of Preferred Stock upon exercise of stock options, net of issuance costs     $ 14,969 $ 114,496        
Issuance of Preferred Stock upon exercise of stock options, net of issuance costs, shares     12,000,000          
Stock-based compensation expense 187         187    
Net loss (6,417)           (6,417)  
Unrealized loss on marketable securities (12)             (12)
Ending balance at Sep. 30, 2020 (32,042)       $ 1 4,184 (36,235) 8
Ending balance, shares at Sep. 30, 2020   40,000,000 28,000,000 62,499,993        
Ending balance at Sep. 30, 2020   $ 37,383 $ 34,276 $ 114,496        
Ending balance, shares at Sep. 30, 2020         6,985,928      
Issuance of Preferred Stock upon exercise of stock options, net of issuance costs, shares       62,499,993        
Issuance of Preferred Stock upon exercise of stock options, net of issuance costs, shares   40,000,000 28,000,000 62,499,993        
Beginning balance at Dec. 31, 2020 (38,147)       $ 1 4,879 (43,014) (13)
Beginning balance, shares at Dec. 31, 2020   40,000,000 28,000,000 62,499,993        
Beginning balance at Dec. 31, 2020 $ 186,151 $ 37,383 $ 34,272 $ 114,496        
Beginning balance, shares at Dec. 31, 2020 7,087,130       7,087,130      
Issuance of common stock upon exercise of stock options $ 123         123    
Issuance of common stock upon exercise of stock options, shares         117,181      
Stock-based compensation expense 835         835    
Net loss (9,299)           (9,299)  
Unrealized loss on marketable securities 22             22
Ending balance at Mar. 31, 2021 (46,466)       $ 1 5,837 (52,313) 9
Ending balance, shares at Mar. 31, 2021   40,000,000 28,000,000 62,499,993        
Ending balance at Mar. 31, 2021   $ 37,383 $ 34,272 $ 114,496        
Ending balance, shares at Mar. 31, 2021         7,204,311      
Beginning balance at Dec. 31, 2020 (38,147)       $ 1 4,879 (43,014) (13)
Beginning balance, shares at Dec. 31, 2020   40,000,000 28,000,000 62,499,993        
Beginning balance at Dec. 31, 2020 $ 186,151 $ 37,383 $ 34,272 $ 114,496        
Beginning balance, shares at Dec. 31, 2020 7,087,130       7,087,130      
Issuance of common stock upon exercise of stock options, shares 65,600              
Net loss $ (33,592)              
Unrealized loss on marketable securities 42              
Ending balance at Sep. 30, 2021 255,649       $ 4 332,222 (76,606) 29
Ending balance, shares at Sep. 30, 2021   0 0 0        
Ending balance, shares at Sep. 30, 2021         40,712,723      
Beginning balance at Mar. 31, 2021 (46,466)       $ 1 5,837 (52,313) 9
Beginning balance, shares at Mar. 31, 2021   40,000,000 28,000,000 62,499,993        
Beginning balance at Mar. 31, 2021   $ 37,383 $ 34,272 $ 114,496        
Beginning balance, shares at Mar. 31, 2021         7,204,311      
Issuance of common stock, net of underwriting discounts and issuance costs 137,166       $ 1 137,165    
Issuance of common stock, net of underwriting discounts and issuance costs, shares         8,825,000      
Conversion of convertible preferred stock to common stock, value   $ (37,383) $ (34,272) $ (114,496)        
Conversion of convertible preferred stock to common stock, shares   (40,000,000) (28,000,000) (62,499,993)        
Conversion of convertible preferred stock to common stock, value 186,151       $ 2 186,149    
Conversion of convertible preferred stock to common stock, shares         24,392,498      
Issuance of contingent common stock, value 831         831    
Issuance of contingent common stock, shares         48,889      
Issuance of common stock upon exercise of stock options 102         102    
Issuance of common stock upon exercise of stock options, shares         100,436      
Stock-based compensation expense 896         896    
Net loss (11,352)           (11,352)  
Unrealized loss on marketable securities 25             25
Ending balance at Jun. 30, 2021 267,353       $ 4 330,980 (63,665) 34
Ending balance, shares at Jun. 30, 2021         40,571,134      
Issuance of common stock upon exercise of stock options 188         188    
Issuance of common stock upon exercise of stock options, shares         141,589      
Stock-based compensation expense 1,054         1,054    
Net loss (12,941)           (12,941)  
Unrealized loss on marketable securities (5)             (5)
Ending balance at Sep. 30, 2021 $ 255,649       $ 4 $ 332,222 $ (76,606) $ 29
Ending balance, shares at Sep. 30, 2021   0 0 0        
Ending balance, shares at Sep. 30, 2021         40,712,723      
Issuance of Preferred Stock upon exercise of stock options, net of issuance costs, shares   0 0 0